Hybio Pharmaceutical Co., Ltd. (SHE:300199)

Hybio Pharmaceutical Revenue

Hybio Pharmaceutical had revenue of 133.68M CNY in the quarter ending September 30, 2025, with 11.86% growth. This brings the company's revenue in the last twelve months to 898.10M, up 121.72% year-over-year. In the year 2024, Hybio Pharmaceutical had annual revenue of 590.20M with 36.82% growth.

• Revenue (ttm): 898.10M
• Revenue Growth: +121.72%
• P/S Ratio: 20.71
• Revenue / Employee: 867.73K
• Employees: 1,035
• Market Cap: 18.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	590.20M	158.81M	36.82%
Dec 31, 2023	431.38M	-272.94M	-38.75%
Jan 1, 2023	704.32M	-31.65M	-4.30%
Jan 1, 2022	735.97M	14.25M	1.97%
Dec 31, 2020	721.72M	107.53M	17.51%